KRT17 and cancer: Conversely, Liang et al. found that K17 by IHC was predictive of a superior response to anti-PD1 blockade in a pilot cohort of 30 missmatch repair deficient (dMMR) colorectal cancer patients, indicating a positive correlation in this cancer type [66].